Horiba haemostasis analyser

HORIBA UK expands range of automated haemostasis analysers

HORIBA is expanding its coagulation range with the UK launch of its new fully automated haemostasis analysers – the high-capacity Yumizen G1500h/G1550h and benchtop Yumizen G800h/G850h. 

Torrey Pines CO20 Column Heater

Torrey Pines Scientific’s new EchoTherm column oven regulates temperatures to ±0.1°C

Torrey Pines Scientific, has unveiled their EchoTherm HPLC Column Oven Model CO20. The temperature range is from room temperature to 90.0°C, readable and settable to 0.1°C. The PID temperature control software regulates temperatures to ±0.1°C. Temperature accuracy and stability are ±0.1ºC with a stable temperature indicator lamp on the front panel that lights when the […]

Euromimmun EPML

EUROIMMUN introduces 89 new assays for ultrafast EUROPattern Microscope Live

EUROIMMUN has introduced 89 new CE-marked indirect immunofluorescence assays (IFA) for use with its EUROPattern Microscope Live, taking the number of products compatible with the device to more than 120. The applications encompass single- and multiplex autoantibody detection on many different tissue, cell and antigen substrates to support diagnosis of autoimmune diseases in the fields […]

GenNext Autofox

GenNext unveils AutoFox – the world’s first fully automated Protein Footprinting System

GenNext Technologies, provider of novel instrumentation, software, and services for structural biology has unveiled their AutoFox Protein Footprinting System, delivering a massive innovation in protein HOS research.

Biotech flowmeter 1

Biotech Fluidics expands range of flowmeters for  real-time monitoring of liquid flow

Biotech Fluidics has expanded its family of non-invasive flowmeters for real-time monitoring of liquid flow. The range now includes four discrete devices optimized to operate from nano-litres per minute up to 650 millilitres per minute.

shutterstock 1291601116

Olink’s new T48 Mouse Cytokine Panel enables deeper preclinical and translational disease research

Olink Holding has introduced their Olink Target 48 Mouse Cytokine Panel, a validated multiplexed protein panel that offers a detailed view of the murine immune system, enabling in-depth disease modelling, longitudinal studies and translational research.

Scherm­afbeelding 2023 10 02 om 16.47.33

Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has updated its flagship platform, Cyto-Mine, enabling it to be compliant with current Good Manufacturing Practice (cGMP) regulations enforced by the US FDA. By meeting these requirements, the company now provides a solution to increase efficiency and productivity of cell […]

CN Bio Tomasz Kostrzewski

CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for micro-physiological systems

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), and LifeNet Health LifeSciences, a non-profit, global leader in human research solutions, will collaborate to supply validated primary human cells for use with CN Bio’s PhysioMimix OOC range of MPS. Under the agreement, LifeNet Health’s high-quality, MPS validated, hepatic […]

ISSCR check list

ISSCR introduces checklist to promote global best practices for human stem cell research

ISSCR introduces checklist to promote global best practices for human stem cell research Recommendations from the Standards for Human Stem Cell Use in Research [1],  published in June by the International Society for Stem Cell Research (ISSCR), include a publishing “checklist” that is now being used by laboratory scientists and implemented in the review process […]

Broken String Felix Dobbs

Broken String Biosciences Closes $15M Series A Funding Round

Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, has closed a US$15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures […]